Muhammad Furqan

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Venues

Future oncology (London, England)

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer medicine

University of Iowa Healthcare

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Iowa Healthcare Jul 01 2014

United States

Associate Professor :: Medicine

Publications

Daniel Morgensztern, Neal E Ready, Melissa Lynne Johnson, Afshin Dowlati, Noura J Choudhury, David P Carbone, Eric Schaefer, Susanne M Arnold, Sonam Puri, Zofia Piotrowska, Aparna Hegde, Anne C Chiang, Wade T Iams, Anthony W Tolcher, Kaname Nosaki, Toshiyuki Kozuki, Tianhong Li, Rafael Santana-Davila, Hiroaki Akamatsu, Haruyasu Murakami, Hiroshi Yokouchi, Song Wang, Jiuhong Zha, Rui Li, Randy R Robinson, Pooja Hingorani, Edwin E Jeng, Muhammad Furqan
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients With Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Muhammad Furqan, Siddharth Karanth, Ravi K Goyal, Beilei Cai, Julien Rombi, Keith L Davis, Nydia Caro, Teddy Saliba
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study. Future oncology (London, England) (2024)
Muhammad Furqan, Siddharth Karanth, Ravi K Goyal, Beilei Cai, Julien Rombi, Keith L Davis, Nydia Caro, Teddy Saliba
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study. Future oncology (London, England) (2024)
Muhammad Furqan, Siddharth Karanth, Ravi K Goyal, Beilei Cai, Julien Rombi, Keith L Davis, Nydia Caro, Teddy Saliba
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study. Future oncology (London, England) (2024)
Muhammad Furqan, Travis P Snyders, Mohammed U Saqlain, Sarah L Mott, Douglas Laux, Anthony Snow, Carryn M Anderson, John M Watkins, Gerald H Clamon
Comparing high-dose cisplatin with cisplatin-based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC). Cancer medicine 8 (6) (2019)

Muhammad Furqan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Muhammad Furqan